Cue Biopharma
CUE
CUE
55 hedge funds and large institutions have $4.95M invested in Cue Biopharma in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
55
Holding in Top 10
–
Calls
–
Puts
$3K
Top Buyers
| 1 | +$81.3K | |
| 2 | +$41.1K | |
| 3 | +$15.6K | |
| 4 |
VF
Virtu Financial
New York
|
+$15.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12.9K |
Top Sellers
| 1 | -$215K | |
| 2 | -$44.9K | |
| 3 | -$21.3K | |
| 4 |
TCBWMS
Texas Capital Bank Wealth Management Services
Dallas,
Texas
|
-$13.5K |
| 5 |
LPL Financial
San Diego,
California
|
-$9.57K |
